Developing a Knowledge Translation Intervention to Improve the Detection and Management of Pediatric Dyslipidemias in
Venessa K Thorsen1,2,3, Stephanie Glegg3,4, Kevin C Harris1,3
1Children's Heart Centre, BC Children's Hospital, Vancouver, British Columbia, Canada.
Insights
A continuing medical education course improved primary care provider adherence to pediatric dyslipidemia guidelines for familial hypercholesterolemia (FH). The course enhanced screening, diagnosis, and treatment, addressing a critical gap in cardiovascular disease prevention.
Area of Science:
- Cardiology
- Genetics
- Medical Education
Background:
- Familial hypercholesterolemia (FH) is a prevalent genetic disorder linked to early cardiovascular disease.
- Awareness and application of Canadian Cardiovascular Society (CCS)/Canadian Pediatric Cardiology Association (CPCA) guidelines for pediatric dyslipidemia are limited among primary care providers.
- A continuing medical education (CME) course was developed to enhance guideline adherence in British Columbia.
Purpose of the Study:
- To evaluate the effectiveness of a CME course in improving primary care provider adherence to pediatric dyslipidemia guidelines.
- To assess changes in self-reported confidence and clinical practices related to FH screening, diagnosis, and management.
- To identify the most effective methods for guideline dissemination in primary care settings.
Main Methods:
- A quasiexperimental pre-/post-knowledge translation study design was employed.
- The CME course was delivered via in-person and remote formats to family physicians and pediatricians.
- Surveys were administered before and one month after the course to measure changes in knowledge, confidence, and adherence.
Main Results:
- Significant improvements were observed in the likelihood of screening pediatric patients for FH (P < 0.001) and confidence in diagnosis (P < 0.001).
- Adherence to recommendations for screening based on risk factors, diagnostic assessments (e.g., family history, counseling), and treatment (e.g., cascade screening, statin initiation) increased notably.
- Participants reported acquiring new knowledge, with 93% finding the CME format effective for guideline dissemination.
Conclusions:
- The CME course successfully promoted uptake of CCS/CPCA guidelines and improved self-reported clinical practices for pediatric dyslipidemia.
- Expanding the CME course to include trainees, nurses, and pharmacists could further enhance its impact and reach.
- Targeted medical education is a viable strategy to address guideline gaps and improve management of genetic lipid disorders in pediatric populations.
Background:
Familial hypercholesterolemia (FH) is a common, underdiagnosed genetic condition associated with premature cardiovascular disease. Despite the availability of Canadian Cardiovascular Society (CCS)/Canadian Pediatric Cardiology Association (CPCA) guidelines, awareness and uptake among primary care providers remain limited. We developed and evaluated a continuing medical education (CME) course to improve adherence to pediatric dyslipidemia guidelines across British Columbia.
Methods:
We conducted a quasiexperimental pre-/post-knowledge translation study. The CME course was delivered in-person at BC Children's Hospital and remotely to urban and rural family physicians and pediatricians. Pre-course and 1-month post-course surveys assessed self-reported confidence and adherence to CCS/CPCA recommendations.
Results:
Likelihood of screening pediatric patients for FH improved significantly after the course (P < 0.001), as did confidence in screening (P < 0.05) and diagnosing FH (P < 0.001). Screening based on risk factors increased significantly: at-risk race and ethnicity (+41%), cardiometabolic conditions (+51%), early-onset high cholesterol (+46%), family history of diabetes (+26%), and premature cardiovascular events in first-degree relatives (+57%). Adherence to diagnostic recommendations improved, including dietary and exercise counseling (+31%), dietician referral (+29%), family history assessment (+46%), and lipid specialist referral (+36%). Treatment adherence also increased: cascade screening (+14%), statin initiation (+23%), dietician referral (+24%), and lipid specialist referral (+36%). Most participants (93%) agreed or strongly agreed that they acquired new knowledge and found the CME to be the most effective format for guideline dissemination.
Conclusions:
The CME course effectively promoted CCS/CPCA guideline uptake and improved self-reported clinical practices. Expanding delivery to include trainees, nurses, and pharmacists may enhance impact and reach.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
13:26Automated Gel Size Selection to Improve the Quality of Next-generation Sequencing Libraries Prepared from Environmental Water Samples
Published on: April 17, 2015
Related Concept Videos
Improving Translational Accuracy
Improving Translational Accuracy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Termination of Translation
